This inventor holds 3 USPTO granted patents. Top assignees: Inner Mongolia University, Inner Mongolia Duhe Innovation R & D Tech Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zongwei Li: Advancing Synthetic Methods for Complex Molecules.
Introduction
Zongwei Li is an inventor associated with Hohhot, China. His patent work includes methods for synthesizing complex organic compounds, including amino acid derivatives and cyclic peptide toxins. The supplied information lists 3 patents.
Latest Patents
Li’s recent patent work includes “Methods for Preparing (2S,3R,4R)-4,5-Dihydroxyisoleucine Derivative and Intermediates Thereof.” The disclosed approach uses a commercially available glycine derivative as its starting material and applies asymmetric allylation, asymmetric dihydroxylation, and protective-group transformations to prepare the target derivative through a series of intermediates.
Another listed invention, “Preparation Method, Intermediates, and Use of Cyclic Peptide Toxin Alpha-Amanitin and/or Amaninamide,” describes total synthesis methods for α-amanitin and amaninamide. The patent disclosure emphasizes commercially accessible reagents, stable intermediates, mild reaction conditions, and practical separation and purification. It also reports gram-scale preparation and identifies potential industrial applications in cyclic peptide toxin synthesis.
Career Highlights
The supplied career information associates Li with Inner Mongolia University and Inner Mongolia Duhe Innovation R & D Tech Co., Ltd. His listed inventions focus on developing practical synthetic routes and intermediates for biologically significant molecules.
Collaborations
Li’s listed coworkers include Guodu Liu and Xinlong Yan. Their names appear in connection with his collaborative research and patent activity.
Conclusion
Zongwei Li’s patent portfolio reflects work on efficient synthetic methods for complex amino acid derivatives and cyclic peptide toxins, with attention to practical preparation and potential scale-up.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile